In vitro combinations of antibiotics and phytochemicals against Pseudomonas aeruginosa

Journal of Microbiology, Immunology and Infection

Volumn 42, Issue 5, 2009, Pages 364-370

  Sakharkar, Meena K ^a,b   Jayaraman, Premkumar ^a,b   Soe, Win Mar ^a,b   Chow, Vincent T K ^c   Sing, Lim Chu ^a   Sakharkar, Kishore R ^a,d  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d NONE   (Singapore)

Author keywords

Caffeic acid; Combined modality therapy; Drug resistance; Protocatechuic acid; Quercetin

Indexed keywords

ANTIBIOTIC AGENT; CAFFEIC ACID; GENTAMICIN; LEVOFLOXACIN; PLANT MEDICINAL PRODUCT; PROTOCATECHUIC ACID; QUERCETIN; SULFADIAZINE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; CAFFEIC ACIDS; DRUG INTERACTIONS; HYDROXYBENZOIC ACIDS; MICROBIAL SENSITIVITY TESTS; PLANT EXTRACTS; PSEUDOMONAS AERUGINOSA; QUERCETIN;

EID: 77749315745     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Schweizer HP. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet Mol Res. 2003;2:48-62.
2. Lee YC, Ahn BJ, JinJS, Kim JU, Lee SH, Song do Y, et al. Molecular characterization of Pseudomonas aeruginosa isolates resistant to all antimicrobial agents, but susceptible to colistin, in Daegu. Korea J Microbiol. 2007:45:358-63.
3. Falagas ME, Bliziotis IA. Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? Int J Antimicrob Agents. 2007;29:630-6.
4. Falagas ME, Bhiziotis IA, Kasiakou SK, Sanionis G, Athnassopoulou P, Michalupoulos A. Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria. BMC Infect Dis. 2005;5:24-30.
5. Bosso JA. The antimicrobial armamentarium: evaluating current and future treatment options. Pharmacotherapy. 2005;25(Suppl):S55-62.
6. Hanser AR, Sriram P. Severe Pseudomonas aeruginosa infections. Tackling the conundrum of drug resistance. Postgrad Med. 2005;117:41-8.
7. Ling TK, Xiong J, Yu Y, Lee CC, Ye H, Hawkey PM. Multicenter antimicrobial susceptibility survey of Gram-negative bacteria isolated from patients with community-acquired infections in the People's Republic of China. Antimicrob Agents Chemother 2006;50:374-8.
8. Eliopoulos GM, Moellering RC. Antimicrobial combinatons. Antibiotics in laboratory medicine. 4th ed. Baltimore: Williams & Wilkins Co.; 1996.
9. Dawis MA, lsenberg HD, France KA, Jenkins SG. In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms. J Antimicrob Chemother. 2003;51:1203-11.
10. Monden K, Ando E, Iida M, Kumon H. Role of fosfomycin in synergistic combination with ofloxacin against Pseudomonas aeruginosa growing in a biofilm. J Infect Chemother. 2002;8:218-26.
11. Song W, Woo HJ, Kim JS, Lee KM. In vitro activity of β-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa. Int J Antimicrob Agents. 2003;21:8-12.
12. Cernohorska L, Votava M. Antibiotic synergy against biofilm-forming Pseudomonas aeruginosa. Folia Microbial. 2008;53:57-60.
13. Neu HC. Synergy and antagonism of combinations of quinolones. Eur J Clin Microbiol Infect Dis. 1991;10:255-61.
14. Donabedian H, Andriole VT. Synergy of vancomycin with penicillins and cephalosporins against Pseudomonas, Klebsiella and Serratia. Yale J Biol Med. 1977;50:165-76.
15. Wise R. Antimicrobial resistance: paradox, actions and economics. J Antimicrob Chemother. 2006;57:1024-5.
16. Gould MI. Antibiotic policies to control hospital-acquired infection. J Antimicrob Chemother. 2008;61:763-5.
17. Amyes SG, Walsh FM, Bradley JS. Best in class: a good principle for antibiotic usage to limit resistance development? J Antimicrob Chemother. 2007;59:825-6.
18. Lewis K, Ausubel FM. Prospects fur plant-derived antibacterials. Nature Biotechnol. 2003;24:1504-7.
19. Cowan MM. Plant products as antimicrobial agents. Clin Microbial Rev. 1999;12:564-82.
20. Cai Y, Wang R, Pei F, Liang BB. Antibacterial activity of allicin alone and in combination with β-lactams against Staphylococcus spp. and Pseudomonas aeruginosa. J Antibiot. 2007;60:335-8.
21. Batista O, Duarte A, Nascimento J, Simōes MF, de Ia Torre MC, Rodríguez B. Structure and antimicrobial activity of diterpenes from the roots of Plectranthus hereroensis. J Nat Prod. 1994;57:858-61.
22. Naacimento GG, Locatelli J, Freitas PC, Silva GL. Antibacterial activity of plant extracts and phytochemicals on antibiotic resistant bacteria. Brazil J Microbiol. 2000;31:247-56.
23. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 5th ed. Approved standard, M7-A5. Wayne: National Committee for Clinical Laboratory Standards; 2000.
24. Methods for determining bactericidal activity of antimicrobial agents. Tentative guidelines M26-T. Wayne: National Committee for Clinical Laboratory Standards; 1992.
25. Stavri M, Piddock LJ, Gibbons S. Bacterial efflux pump inhibitors flvm natural sources. J Antimicrob Chemother 2007;59:1247-60.
26. Barber M. Drug combinations in antibacterial chemotherapy. Proc R Soc Med. 1965;58:990-5.